A review characterized a rare standing-related tremor syndrome. Reported medication benefit came largely from case literature rather than controlled comparative trials.
The clinical spectrum
The review identified seventy electrophysiologically confirmed slow orthostatic tremor cases. Many had associated neurologic disorders, including parkinsonism, ataxia, or dystonia.
Clonazepam was reported as the most effective medicine across frequencies, while other treatments appeared useful in selected subgroups. Some cases improved after treating an underlying disease.
Reported success is selected evidence
Missing clinical details, variable electrophysiology, and publication bias limit estimates of treatment response. Different underlying conditions may also represent distinct syndromes.
The paper cannot establish a general clonazepam success rate, optimal dose, or identical benefit for classical and slow tremor. Forensic interpretation should retain the standing trigger, recorded frequency, associated disease, functional effect, and treatment timeline. A published case response does not prove every episode of unsteadiness is the same disorder or that medication benefit excludes medication-related adverse effects.
Source paper
Original analysis of the supplied journal article, identified as PMC6886496.
Leave a Reply